Zurück

Wählen Sie Ihre Region

Corporate

Europa:

Flagge Albanien Albanien Flagge Bosnien-Herzegowina Bosnien-Herzegowina Flagge Bulgarien Bulgarien Flagge Kroatien Kroatien Flagge Zypern Zypern Flagge Montenegro Montenegro Flagge Tschechien Tschechien Flagge Dänemark Dänemark Flagge Estland Estland Flagge Spanien Spanien Flagge Kosovo Kosovo Flagge Litauen Litauen Flagge Lettland Lettland Flagge Luxemburg Luxemburg Flagge Mazedonien Mazedonien Flagge Deutschland Deutschland Flagge Polen Polen Flagge Portugal Portugal Flagge Rumänien Rumänien Flagge Serbien Serbien Flagge Slowakei Slowakei Flagge Slowenien Slowenien Flagge Schweiz Schweiz Flagge Schweden Schweden Flagge Türkei Türkei Flagge Ungarn Ungarn Flagge Großbritannien Großbritannien Flagge Italien Italien

Asien:

Flagge UAE UAE Flagge Hong Kong Hong Kong Flagge Kuwait Kuwait Flagge Libanon Libanon

Afrika:

Flagge Südafrika Südafrika

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Kontaktieren Sie uns noch heute!

Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.

    Wir möchten Sie darauf hinweisen, dass die im Formular angegebenen personenbezogenen Daten von FamiCord Suisse mit Sitz in der Schweiz (BusinessPark Zug Sumpfstrasse 26, 6302 Zug) zur telefonischen Kontaktaufnahme im Zusammenhang mit der Erteilung von Serviceinformationen verarbeitet werden.

    Obraz

    Unsere
    Transplantationen

    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

    Obraz
    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
    Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
    501 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 72
    502 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 70
    503 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 61
    504 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Lithuania 62
    505 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Australia 62
    506 Apheresis Allogeneic Myelofibrosis Hematology 2026 Standard Therapy Spain 61
    507 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 58
    508 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy India 2
    509 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2026 Standard Therapy Germany 21
    510 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 63
    511 Apheresis Autologous Diffuse Large B-cell Lymphoma Hematology 2026 Standard Therapy Germany 71
    512 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2026 Standard Therapy Germany 61
    513 Apheresis Autologous Mantle Cell Lymphoma Hematology 2026 Standard Therapy Germany 65
    514 Apheresis Autologous T-Cell Lymphoma Hematology 2026 Standard Therapy Germany 64
    515 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 70
    516 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 59
    517 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 66
    518 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 61
    519 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 53
    520 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2026 Standard Therapy France 26
    521 Apheresis Allogeneic Inherited Metabolic Disorder Hematology 2026 Standard Therapy France 50
    522 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 70
    523 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 70
    524 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Argentina 30
    525 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 74
    526 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 61
    527 Apheresis Allogeneic Hyper IgE Syndrome Hematology 2026 Standard Therapy Australia 11
    528 Apheresis Allogeneic AML FLT3+ Hematology 2026 Standard Therapy Croatia 61
    529 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 61
    530 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Australia 58
    531 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Iran 3
    532 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy USA 59
    533 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 58
    534 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 10
    535 Apheresis Allogeneic Lymphoma – Peripheral T cell Hematology 2026 Standard Therapy United Kingdom 53
    536 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Italy 48
    537 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Spain 13
    538 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Italy 58
    539 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2026 Standard Therapy USA 69
    540 Apheresis Allogeneic Peripheral T Cell Lymphoma With Haemophagocytic Lymphohistiocytosis Hematology 2026 Standard Therapy United Kingdom 52
    541 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Germany 62
    542 Apheresis Allogeneic T-Cell Prolymphocytic Leukemia Hematology 2026 Standard Therapy Italy 72
    543 Apheresis Allogeneic Myelodysplastic Disorder Hematology 2026 Standard Therapy Russian Federation 51
    544 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 64
    545 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 62
    546 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy USA 49
    547 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy USA 75
    548 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 68
    549 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 58
    550 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Spain 52
    551 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 69
    552 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 20
    553 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 65
    554 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Belgium 34
    555 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 67
    556 Apheresis Allogeneic Myelofibrosis Hematology 2026 Standard Therapy Poland 69
    557 Apheresis Allogeneic T-Cell Acute lymphoblastic leukemia Hematology 2026 Standard Therapy Netherlands 21
    558 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 70
    559 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy USA 68
    560 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 16
    561 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 65
    562 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 61
    563 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 65
    564 Apheresis Autologous Central Nervous System Lymphoma Hematology 2026 Standard Therapy Germany 65
    565 Apheresis Autologous Diffuse Large B-cell Lymphoma Hematology 2026 Standard Therapy Germany 45
    566 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 61
    567 Apheresis Allogeneic B-cell Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Germany 21
    568 Apheresis Autologous Mantle Cell Lymphoma Hematology 2026 Standard Therapy Germany 65
    569 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 68
    570 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Ukraine 5
    571 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy Hungary 57
    572 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 30
    573 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 37
    574 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 57
    575 Apheresis Allogeneic Thalassemia Major Hematology 2026 Standard Therapy Turkey 1
    576 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 59
    577 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Switzerland 65
    578 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 28
    579 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Estonia 67
    580 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Czechia 28
    581 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 71
    582 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 73
    583 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 73
    584 Apheresis Allogeneic Acute Myeloblastic Leukemia Hematology 2026 Standard Therapy Romania 62
    585 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 62
    586 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy USA 52
    587 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 71
    588 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Spain 48
    589 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy USA 59
    590 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 52
    591 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 43
    592 Apheresis Allogeneic Akut Myeloid Leukemia Hematology 2026 Standard Therapy Turkey 48
    593 Apheresis Allogeneic Chronic myelomonocytic leukemia Hematology 2026 Standard Therapy Finland 16
    594 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 30
    595 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy Germany 72
    596 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 50
    597 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 70
    598 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Spain 45
    599 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 75
    600 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 39